Beta Bionics, Inc. (BBNX) vs SI-BONE, Inc. (SIBN)
A side-by-side comparison of Beta Bionics, Inc. and SI-BONE, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBNX
Beta Bionics, Inc.
$18.63HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SIBN
SI-BONE, Inc.
$19.55HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BBNX vs SIBN
growth of $100 · dividends reinvested · last 2yBBNX -19.8% (-10.4%/yr)SIBN +15.0% (+7.3%/yr)SIBN compounded faster over this window
BBNX SIBN
BBNX vs SIBN: by the numbers
- •SIBN is the larger company ($867M vs $838M market cap).
- •Both run net losses; SIBN's is the smaller (-6.85% vs -61.32% net margin).
Metrics side by side
Valuation
| Metric | BBNX | SIBN |
|---|---|---|
| P/S ratio | 7.04 | 4.06 |
| P/B ratio | 3.27 | 4.75 |
Profitability
| Metric | BBNX | SIBN |
|---|---|---|
| Gross margin | 58.31% | 79.53% |
| Operating margin | -69.75% | -8.31% |
| Net margin | -61.32% | -6.85% |
| ROE | -28.46% | -8.03% |
| ROIC | -31.17% | -7.88% |
Growth (annualized)
| Metric | BBNX | SIBN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 20.20% |
| Total return CAGR (5Y) | N/A | -1.46% |
Go deeper
Dig into the metrics
Beta Bionics ROESI-BONE ROEBeta Bionics operating marginSI-BONE operating marginBeta Bionics revenue growthSI-BONE revenue growthBeta Bionics free cash flowSI-BONE free cash flow
Beta Bionics & SI-BONE appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.